Long COVID: What we know and tips to improve it | Nullure

Long COVID: What we know and tips to improve it | Nullure

Immagine del profilo Zeynep Özdemir
Zeynep Özdemir

Una dietista nutrizionista certificata che unisce una formazione scientifica accademica, la passione per la salute e una vasta conoscenza della sicurezza alimentare.

Long COVID remains a pressing issue as millions worldwide continue to suffer from its prolonged impacts, even after recovering from the initial viral infection. This condition encompasses a broad spectrum of symptoms affecting various body systems, presenting significant challenges for patients and healthcare providers alike. Understanding its mechanisms, potential treatments, and effective management strategies is crucial for alleviating the long-term effects on patients' health and quality of life.


What is Long COVID?

Long COVID, also known as post-acute COVID-19 syndrome (PASC) or long-haul COVID, is defined as a complex condition characterized by symptoms that are not explained by other diagnoses and persist for more than 12 weeks following the initial recovery from COVID-19. This condition can affect anyone who has recovered from COVID-19, regardless of how mild or severe their initial infection was. These symptoms continue to impact daily functioning and health well beyond the acute phase of the virus. (1, 2, 3)

Common Symptoms of Long COVID

Individuals with long COVID may experience a wide array of symptoms, which can vary greatly in their combination and severity. Common symptoms include:
Long COVID Fatigue: This is one of the most reported symptoms, where individuals feel unusually tired and unable to perform daily activities.(1, 4)

  • Long COVID Brain Fog: Cognitive issues such as difficulty concentrating, confusion, and forgetfulness are frequent complaints. (4, 5)
  • Long COVID Breathing Problems: Persistent shortness of breath and difficulty breathing are common, even in mild COVID-19 cases. (6)
  • Allergy-Like Symptoms: Many individuals report symptoms similar to allergies, including itchy eyes, sore throat, and runny nose. (1, 7)
  • Digestive Symptoms: Gastrointestinal issues such as nausea, diarrhea, and abdominal pain are increasingly recognized as part of Long COVID. (8)
  • Long COVID Heart Problems: Patients may experience palpitations, chest pain, or an increased heart rate. (1)
  • Long COVID Headaches and Migraines: Frequent headaches and migraines are reported, which can be debilitating. (4, 5, 6)
  • Others: Symptoms can also include loss of taste and smell, joint and muscle pain, and sleep disturbances. (9)

These symptoms can severely impact the quality of life and ability to work, leading to a significant burden on health systems and economies due to the long-term disability some patients face. The pathophysiology of these symptoms is complex, involving immune dysregulation, potential viral reservoirs, and widespread inflammation across multiple organ systems.

Long COVID: What we know and tips to improve it | Nullure

Current Research on Long COVID

Current research on Long COVID is extensive, focusing on unraveling the condition's complex causes and potential treatments. Among the key areas of interest is the role of genetic predispositions. Studies on Single Nucleotide Polymorphisms (SNPs) have begun to shed light on why some individuals experience more severe or prolonged symptoms than others. These genetic factors may influence both the susceptibility to Long COVID and the severity of its symptoms, providing crucial insights into personalized treatment approaches and prevention strategies. Key areas include:

Genetic Predispositions:

Studies on Single Nucleotide Polymorphisms (SNPs) suggest genetic factors may influence susceptibility to Long COVID and the severity of its symptoms. These findings provide critical insights into personalized treatment and prevention strategies. (10)

Immune System Dysregulation:

Persistent alterations in immune cell functions indicate chronic immune activation. This includes changes in T cell functions, such as exhaustion and reduced memory cell numbers, alongside elevated interferon levels. (11, 12)

Extended activation of innate immune cells and changes in T and B cell populations, coupled with elevated cytokine levels, drive ongoing inflammation. (1, 11, 16)

Prolonged Activity of Non-Classical Monocytes:

These immune cells, involved in inflammation and immune surveillance, remain active beyond the acute phase of infection, driving sustained inflammation and delaying recovery. (13)

Viral Persistence and Reactivation:

Inadequate initial immune responses allow viruses like Epstein-Barr Virus (EBV), Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), and Cytomegalovirus (CMV) to persist or reactivate, prolonging symptoms and complicating recovery. (11, 14, 15, 16)

Autoantibody Production:

High levels of autoantibodies targeting critical receptors like ACE2 have been identified, contributing to cardiovascular symptoms and systemic immune dysregulation. (11, 12, 17)

Allergy Activation and Mast Cell Activation Syndrome (MCAS):

Long COVID may activate allergy-like responses, including MCAS, leading to exacerbated inflammatory responses and complicating symptom management. (18, 19)

Microbiome Shifts:

Alterations in the gut microbiome have been linked to Long COVID, affecting immune responses and potentially contributing to symptom severity and duration. (20)

Vascular Damage and Clotting:

The virus’s impact on vascular systems can lead to widespread organ and tissue damage. Chronic inflammation may induce vascular inflammation and clotting, which are pivotal in understanding Long COVID's long-term health effects. (21)

Clinical trials are testing various Long COVID treatment options, including antivirals, immunotherapies, and interventions to address autoimmunity and vascular health, aiming to tailor interventions to the specific pathophysiological features observed in Long COVID. 

Tips for Managing Long COVID Symptoms

Dealing with long COVID involves a multidimensional approach that addresses both the physical and psychological aspects of the condition, helping individuals regain their health and improve their quality of life.

Lifestyle Modifications

Effective management of long COVID-19 symptoms can be significantly supported by adopting certain lifestyle changes:

  • Rest, Rest, Rest: For individuals with Long COVID, prioritizing rest is essential. Deep rest without physical exertion is recommended until noticeable symptom improvement occurs. This approach allows the body to allocate its resources towards recovery without the additional stress that exercise might introduce. Rest can aid in reducing systemic inflammation and help stabilize the body's systems, which is crucial for those in the recovery phase of Long COVID. (22, 23)
  • Balanced Diet: Consuming a diet rich in fruits, vegetables, lean proteins, and whole grains helps bolster the immune system and aids in overall recovery. Nutrients like vitamins C and D, zinc, and omega-3 fatty acids are particularly important for their roles in reducing inflammation and supporting immune health. The inclusion of colorful vegetables is particularly emphasized due to their strong anti-inflammatory effects. (24, 25)
  • Intermittent Fasting: Consider intermittent fasting as a method to enhance autophagy, which can aid the body's natural healing processes and potentially alleviate some symptoms associated with Long COVID. (26, 27)
  • Stress Management: Engaging in stress-reducing practices such as mindfulness, meditation, or tai chi can lower stress hormones like cortisol, which when elevated, can exacerbate long COVID symptoms and impede recovery. (28)
  • Far Infrared Exposure: Exposure to far infrared can help with symptoms management by promoting circulation and possibly aiding in detoxification processes, which might be beneficial for Long COVID patients. (29)
  • Vagus Nerve Stimulation: Techniques that stimulate the vagus nerve can be beneficial, as they may help in reducing inflammation and improving autonomic nervous system function, both of which are crucial for those recovering from Long COVID. (30, 31)

Vagus Nerve Stimulation Techniques:

  1. Diaphragmatic Breathing: Slow, deep breathing that engages the diaphragm has been shown to activate the vagus nerve. Breathing exercises with extended exhalation (e.g., inhale for 4 seconds, exhale for 6–8 seconds) help reduce heart rate and calm the autonomic nervous system. (32)
  2. Cold Exposure: Applying cold to the face, such as splashing with cold water or using a cold pack, can stimulate the vagus nerve through the diving reflex. This practice supports parasympathetic activity and reduces stress responses. (33)
  3. Gargling: Gargling activates muscles in the throat connected to the vagus nerve, potentially enhancing vagal tone and autonomic regulation. (33, 34)
  4. Humming or Vocal Exercises: Humming or chanting creates vibrations in the vocal cords, which can stimulate the vagus nerve. Singing has also been shown to enhance parasympathetic activity. (35)
  5. Mindfulness Meditation: Practices focusing on awareness of breath and body sensations promote vagal activation by reducing stress hormones and improving autonomic balance. (28, 31)
Long COVID: What we know and tips to improve it | Nullure

Complementary and Alternative Therapies

Focusing exclusively on supplements, several have been identified that may support recovery from Long COVID symptoms by addressing mitochondrial dysfunction, inflammation, and vascular health:

Supplements for Mitochondrial Support:

  • Alpha-Lipoic Acid (ALA): Enhances mitochondrial enzyme activity and acts as a powerful antioxidant, helping to improve energy production and protect cells from oxidative stress. (36)
  • Carnitine: Plays a vital role in transporting fatty acids into mitochondria for energy generation, supporting muscle function and cardiovascular health. (37)
  • Coenzyme Q10 (CoQ10): Facilitates the production of cellular energy by assisting mitochondrial electron transport and reducing oxidative damage, which can alleviate fatigue and improve physical endurance. (38)
  • Creatine: Supports cellular energy regeneration by aiding ATP production, which is critical for muscle recovery and overall energy levels. (39)

Green Tea: Packed with polyphenols like epigallocatechin gallate (EGCG), green tea provides antioxidant and anti-inflammatory benefits that may help reduce chronic inflammation commonly seen in Long COVID. (40)

Luteolin: A flavonoid with strong anti-inflammatory and antioxidant properties, luteolin can help mitigate systemic inflammation and support immune regulation. (41)

Butyrate: This short-chain fatty acid is essential for gut health and immune modulation. It aids in restoring the gut barrier, reducing inflammation, and supporting a balanced immune response. (42, 43)

Nattokinase: A natural enzyme derived from fermented soybeans, nattokinase supports vascular health by promoting blood flow and addressing issues related to clotting and inflammation, which are common in Long COVID. (44)

Support and Resources

Accessing strong support and specialized healthcare resources is crucial for managing long COVID, offering vital connections and personalized care strategies.

Online Communities and Support Groups

Connecting with others through online communities and long COVID support groups can be incredibly beneficial for those dealing with long COVID. These platforms offer a space to exchange information, receive support, and learn from others' experiences, reducing feelings of isolation and providing coping strategies shared by those in similar situations. (45, 46)

Healthcare Professionals Specialized in Long COVID

Healthcare providers specializing in long COVID are essential for comprehensive care. These specialists understand the complex nature of the condition and can guide patients through their long COVID recovery. They coordinate with various professionals, such as dietitians, physiotherapists, and mental health experts, to create a personalized care plan that addresses all aspects of the patient’s health, improving their overall management of the condition. (1)

Torna al blog

Lascia un commento

Elenco di riferimento

1. Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133-146. https://doi.org/10.1038/s41579-022-00846-2
2. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13. Erratum in: Nat Rev Microbiol. 2023 Jun;21(6):408. doi: 10.1038/s41579-023-00896-0. PMID: 36639608; PMCID: PMC9839201.
3. Fernández-de-Las-Peñas, C., Raveendran, A. V., Giordano, R., & Arendt-Nielsen, L. (2023). Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions. Microorganisms, 11(12), 2959. https://doi.org/10.3390/microorganisms11122959
4. Gross, M., Lansang, N. M., Gopaul, U., Ogawa, E. F., Heyn, P. C., Santos, F. H., Sood, P., Zanwar, P. P., Schwertfeger, J., & Faieta, J. (2023). What Do I Need to Know About Long-Covid-related Fatigue, Brain Fog, and Mental Health Changes?. Archives of physical medicine and rehabilitation, 104(6), 996–1002. https://doi.org/10.1016/j.apmr.2022.11.021
5. Chasco, E. E., Dukes, K., Jones, D., Comellas, A. P., Hoffman, R. M., & Garg, A. (2022). Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID. International journal of environmental research and public health, 19(23), 15499. https://doi.org/10.3390/ijerph192315499
6. Green M, Marzano V, Faustini S, et al. Headaches and long COVID: a clinical study. Headache. 2021;61(4):560-570.
7. Miller RF, Sterling JK, Spagnuolo V. Allergy symptoms and COVID-19: what we know so far. Allergy Asthma Proc. 2022;43(2):98-105.
8. Brown C, Patel D. Gastrointestinal manifestations of long COVID. Gastroenterol Rep. 2021;9(1):22-28.
9. Taylor S, Landry CA, Paluszek MM, et al. COVID-19 and fatigue: a comprehensive review. J Affect Disord. 2021;285:85-91.
10. Balzanelli MG, Distratis P, Lazzaro R, Pham VH, Tran TC, Dipalma G, Bianco A, Serlenga EM, Aityan SK, Pierangeli V, Nguyen KCD, Inchingolo F, Tomassone D, Isacco CG. Analysis of Gene Single Nucleotide Polymorphisms in COVID-19 Disease Highlighting the Susceptibility and the Severity towards the Infection. Diagnostics (Basel). 2022 Nov 16;12(11):2824. doi: 10.3390/diagnostics12112824. PMID: 36428884; PMCID: PMC9689844.
11. Constantinescu-Bercu, A., Lobiuc, A., Căliman-Sturdza, O. A., Oiţă, R. C., Iavorschi, M., Pavăl, N. E., Șoldănescu, I., Dimian, M., & Covasa, M. (2023). Long COVID: Molecular Mechanisms and Detection Techniques. International journal of molecular sciences, 25(1), 408. https://doi.org/10.3390/ijms25010408
12. Yin, K., Peluso, M. J., Luo, X., Thomas, R., Shin, M. G., Neidleman, J., Andrew, A., Young, K., Ma, T., Hoh, R., Anglin, K., Huang, B., Argueta, U., Lopez, M., Valdivieso, D., Asare, K., Deveau, T. M., Munter, S. E., Ibrahim, R., Ständker, L., … Roan, N. R. (2023). Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv : the preprint server for biology, 2023.02.09.527892. https://doi.org/10.1101/2023.02.09.527892
13. Phetsouphanh, C., & Patterson, B. K. (2021). Non-classical monocytes and prolonged immune activation in long COVID patients. Journal of Clinical Immunology, 41(5), 897-912. https://doi.org/10.1007/s10875-021-01053-1
14. Sapir, T., Averch, Z., Lerman, B., Bodzin, A., Fishman, Y., & Maitra, R. (2022). COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. International journal of molecular sciences, 23(15), 8606. https://doi.org/10.3390/ijms23158606
15. Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. (2023). The role of immune activation and antigen persistence in acute and long COVID. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 71(5), 545–562. https://doi.org/10.1177/10815589231158041
16. Mohan, A., Iyer, V. A., Kumar, D., Batra, L., & Dahiya, P. (2023). Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response. Life (Basel, Switzerland), 13(11), 2121. https://doi.org/10.3390/life13112121
17. Tsilingiris, D., Vallianou, N. G., Karampela, I., Christodoulatos, G. S., Papavasileiou, G., Petropoulou, D., Magkos, F., & Dalamaga, M. (2022). Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. International Journal of Molecular Sciences, 24(13), 10458. https://doi.org/10.3390/ijms241310458
18. Bradley, T., Geanes, E., McLennan, R., & LeMaster, C. (2023). Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity. Research square, rs.3.rs-3304083. https://doi.org/10.21203/rs.3.rs-3304083/v1
19. Sideratou, C., & Papaneophytou, C. (2024). Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis. Infectious Disease Reports, 16(4), 561-571. https://doi.org/10.3390/idr16040042
20. Peluso, M. J., Ryder, D., Flavell, R., Wang, Y., Levi, J., LaFranchi, B. H., Deveau, T. M., Buck, A. M., Munter, S. E., Asare, K. A., Aslam, M., Koch, W., Szabo, G., Hoh, R., Deswal, M., Rodriguez, A., Buitrago, M., Tai, V., Shrestha, U., Lu, S., … Henrich, T. J. (2023). Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19. medRxiv : the preprint server for health sciences, 2023.07.27.23293177. https://doi.org/10.1101/2023.07.27.23293177
21. Buonsenso, D., Piazza, M., Boner, A. L., & Bellanti, J. A. (2022). Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy and asthma proceedings, 43(3), 187–193. https://doi.org/10.2500/aap.2022.43.220018
22. Ennis S, Heine P, Sandhu H, Sheehan B, Yeung J, McWilliams D, Jones C, Abraham C, Underwood M, Bruce J, Seers K, McGregor G. Development of an online intervention for the Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN (REGAIN) trial. NIHR Open Res. 2023 Jul 14;3:10. doi: 10.3310/nihropenres.13371.2. PMID: 37881468; PMCID: PMC10593321.
23. Shao T, Verma HK, Pande B, Costanzo V, Ye W, Cai Y, Bhaskar LVKS. Physical Activity and Nutritional Influence on Immune Function: An Important Strategy to Improve Immunity and Health Status. Front Physiol. 2021 Oct 8;12:751374. doi: 10.3389/fphys.2021.751374. PMID: 34690818; PMCID: PMC8531728.
24. Jia, G., & Su, C. (2023). Tailored Physical Activity Interventions for Long COVID: Current Approaches and Benefits—A Narrative Review. Healthcare, 12(15), 1539. https://doi.org/10.3390/healthcare12151539
25. Shan T, Li LY, Yang JM, Cheng Y. Role and clinical implication of autophagy in COVID-19. Virol J. 2023 Jun 16;20(1):125. doi: 10.1186/s12985-023-02069-0. PMID: 37328875; PMCID: PMC10276507.
26. Shabkhizan R, Haiaty S, Moslehian MS, Bazmani A, Sadeghsoltani F, Saghaei Bagheri H, Rahbarghazi R, Sakhinia E. The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting. Adv Nutr. 2023 Sep;14(5):1211-1225. doi: 10.1016/j.advnut.2023.07.006. Epub 2023 Jul 30. PMID: 37527766; PMCID: PMC10509423.
27. Halma, M. T., Marik, P. E., & Saleeby, Y. M. (2024). Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology. Endocrine and Metabolic Science, 14, 100163. https://doi.org/10.1016/j.endmts.2024.100163
28. Porter N, Jason LA. Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning. Neuropsychiatr Dis Treat. 2022 Nov 8;18:2599-2626. doi: 10.2147/NDT.S379653. PMID: 36387947; PMCID: PMC9653042.
29. Padilla, Jacqueline & Faller, Erwin. (2021). Combined therapy of far infrared radiation, heat and castor oil, an alternative remedy against Covid-19 infection: A perspective. GSC Biological and Pharmaceutical Sciences. 16. 1-012. 10.30574/gscbps.2021.16.3.0257.
30. Khan, M. W., Ahmad, M., Qudrat, S., Afridi, F., Khan, N. A., Afridi, Z., Azeem, T., & Ikram, J. (2024). Vagal nerve stimulation for the management of long COVID symptoms. Infectious Medicine, 3(4), 100149. https://doi.org/10.1016/j.imj.2024.100149
31. Basharat S, Mahood Q; Authors. Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition: Health Technology Update [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep. Available from: https://www.ncbi.nlm.nih.gov/books/NBK603323/
32. Gerritsen RJS, Band GPH. Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative Activity. Front Hum Neurosci. 2018 Oct 9;12:397. doi: 10.3389/fnhum.2018.00397. PMID: 30356789; PMCID: PMC6189422.
33. Richer R, Zenkner J, Küderle A, Rohleder N, Eskofier BM. Vagus activation by Cold Face Test reduces acute psychosocial stress responses. Sci Rep. 2022 Nov 10;12(1):19270. doi: 10.1038/s41598-022-23222-9. PMID: 36357459; PMCID: PMC9649023.
34. Howland RH. Vagus Nerve Stimulation. Curr Behav Neurosci Rep. 2014 Jun;1(2):64-73. doi: 10.1007/s40473-014-0010-5. PMID: 24834378; PMCID: PMC4017164.
35. Trivedi, G., Sharma, K., Saboo, B., Kathirvel, S., Konat, A., Zapadia, V., Prajapati, P. J., Benani, U., Patel, K., & Shah, S. (2023). Humming (Simple Bhramari Pranayama) as a Stress Buster: A Holter-Based Study to Analyze Heart Rate Variability (HRV) Parameters During Bhramari, Physical Activity, Emotional Stress, and Sleep. Cureus, 15(4), e37527. https://doi.org/10.7759/cureus.37527
36. Dieter F, Esselun C, Eckert GP. Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells. Int J Mol Sci. 2022 Aug 16;23(16):9186. doi: 10.3390/ijms23169186. PMID: 36012451; PMCID: PMC9409376.
37. Virmani MA, Cirulli M. The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int J Mol Sci. 2022 Feb 28;23(5):2717. doi: 10.3390/ijms23052717. PMID: 35269860; PMCID: PMC8910660.
38. Sood B, Patel P, Keenaghan M. Coenzyme Q10. [Updated 2024 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531491/
39. Saito S, Cao DY, Okuno A, Li X, Peng Z, Kelel M, Tsuji NM. Creatine supplementation enhances immunological function of neutrophils by increasing cellular adenosine triphosphate. Biosci Microbiota Food Health. 2022;41(4):185-194. doi: 10.12938/bmfh.2022-018. Epub 2022 Jun 17. PMID: 36258765; PMCID: PMC9533032.
40. Mokra, D., Joskova, M., & Mokry, J. (2022). Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. International Journal of Molecular Sciences, 24(1), 340. https://doi.org/10.3390/ijms24010340
41. Ntalouka F, Tsirivakou A. Luteolin: A promising natural agent in management of pain in chronic conditions. Front Pain Res (Lausanne). 2023 Mar 1;4:1114428. doi: 10.3389/fpain.2023.1114428. PMID: 36937566; PMCID: PMC10016360.
42. Siddiqui MT, Cresci GAM. The Immunomodulatory Functions of Butyrate. J Inflamm Res. 2021 Nov 18;14:6025-6041. doi: 10.2147/JIR.S300989. PMID: 34819742; PMCID: PMC8608412.
43. Feng, C., Jin, C., Liu, K., & Yang, Z. (2023). Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections. Biomedicine & Pharmacotherapy, 160, 114414. https://doi.org/10.1016/j.biopha.2023.114414
44. Tanikawa T, Kiba Y, Yu J, Hsu K, Chen S, Ishii A, Yokogawa T, Suzuki R, Inoue Y, Kitamura M. Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules. 2022 Aug 24;27(17):5405. doi: 10.3390/molecules27175405. PMID: 36080170; PMCID: PMC9458005.
45. Micklesfield LK, Munro S, Levitt N, Lambert EV. Peer support for people with chronic conditions: a systematic review of quantitative and qualitative data. BMC Health Serv Res. 2022;22(1):1016. doi:10.1186/s12913-022-07816-7.
46. White M, Dorman SM. Receiving social support online: implications for health education. Health Educ Res. 2001 Dec;16(6):693-707. doi:10.1093/her/16.6.693.